PE-backed Charles River to buy MPI Research for about $800 mln

Charles River Laboratories International has agreed to acquire MPI Research, a provider of testing services for biopharmaceutical and medical devices, for about $800 million in cash. Morgan Stanley is serving as financial adviser to Charles River on the transaction while Jefferies LLC and SunTrust Robinson Humphrey Inc are doing likewise for MPI. Charles River is backed by Avista Capital Partners.

DealsNorth AmericaUSHealthcareBriefs